1 Followers on Owler
OverviewFundingNews & Insights

Anticancer Bioscience Funding History

Since Anticancer Bioscience was founded in 2016, it has participated in 2 rounds of funding. In total Anticancer Bioscience has raised $20.6M. Anticancer Bioscience's last funding round was on Oct 2021 for a total of $10.6M.

Anticancer Bioscience Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Seed
Oct 2021
$10.6M
1
Three Rivers Capital
Equity
Feb 2021
$10M
__

Total Funding: $20.6M

Anticancer Bioscience Investors

INVESTOR

ROUND

FUNDING DATE

Three Rivers Capital
Seed
Oct 2021

Total Investors: 1

Anticancer Bioscience has 1 investors, including and Three Rivers Capital. The latest investment occurred in Oct 2021.